家禽診断市場規模、シェア、動向、2031年までの世界予測

家禽診断市場は、2026年の1億8,000万米ドルから2031年には2億5,000万米ドルに成長し、年平均成長率（CAGR）は7.1%になると予測されています。この成長は、家禽疾病の診断、監視、および群れの健康管理の未来を形作るいくつかの重要な要因によって推進されています。家禽診断市場の主な推進力は、世界的な商業家禽生産の急速な拡大と、大規模な群れにおける感染症の発生を制御する必要性の高まりです。家禽飼育がより集約的になるにつれて、畜産企業は、生産損失を防ぎ、群れの継続的な生産性を確保するための重要な戦略として、疾病の早期発見と定期的な健康監視を採用しています。その結果、家禽農場、獣医研究所、および総合家禽企業は、PCRやELISAなどの高度な診断方法を使用して、鳥インフルエンザ、ニューカッスル病、伝染性気管支炎などの病原体を迅速かつ正確に特定するようになっています。

需要を押し上げるもう一つの重要な要因は、世界の家禽サプライチェーン全体におけるバイオセーフティ、食料安全保障、および規制対象疾病の管理に対する注目度の高まりです。各国政府、国際機関、そして家禽農家は、食肉や卵の生産に大きな損失をもたらし、国際貿易を混乱させる可能性のある大規模な疾病発生に備えるため、疾病追跡システムを強化しています。その結果、家禽検査における診断技術の利用は、生産施設への安全なアクセスを容易にし、生産者と獣医当局が安定した生産レベルを維持しながら、タイムリーな封じ込め措置を実施できるようにするための一般的な慣行となっています。

調査範囲

本市場調査は、家禽診断市場を様々なセグメントに分けて分析しています。製品タイプ、検査タイプ、疾病タイプ、家禽タイプ、サンプルタイプ、エンドユーザー、地域別に市場規模と成長可能性を推定することを目的としています。また、主要企業の詳細な競合分析に加え、企業プロファイル、製品および事業内容に関する重要な考察、最近の動向、主要な市場戦略についても詳述しています。

本レポートを購入する理由

本レポートは、既存企業はもちろん、新規参入企業や中小企業が市場動向を理解し、より大きな市場シェアを獲得するのに役立ちます。本レポートを購入した企業は、以下に概説する5つの戦略のうち、1つ以上を実行することができます。

本レポートは、以下の点について考察します。

家禽診断市場の成長に影響を与える主要な推進要因（国境を越える感染症および風土病の発生率の上昇、商業・工業規模の家禽生産の増加）、阻害要因（高度な分子検査プラットフォームの高コスト、開発途上地域における診断インフラの不足）、機会（新興家禽市場における地理的拡大、迅速なポイントオブケア（POC）検査の開発）、および課題（ウイルス病原体の急速な変異と株の多様性、小規模農家や家庭養鶏農家における認知度の低さ）の分析。

• 製品開発／イノベーション：家禽診断市場における今後の技術と製品発売に関する詳細な考察。
• 市場開発：有望な新興市場に関する包括的な情報。本レポートは、地域ごとの様々なタイプの家禽診断製品市場を分析します。
• 市場の多様化：家禽診断市場における製品、未開拓地域、最近の動向、および投資に関する包括的な情報。
• 競合分析：家禽診断市場における主要企業の市場シェア、戦略、製品、流通ネットワーク、製造能力に関する詳細な分析。

Report Description

The poultry diagnostics market is projected to grow from USD 0.18 billion in 2026 to USD 0.25 billion by 2031, at a CAGR of 7.1%. This growth is driven by several key factors that are shaping the future of poultry disease diagnostics, surveillance, and flock health management. The primary driver of the poultry diagnostics market is the rapid expansion of commercial poultry production worldwide and the increasing demand to control infectious disease outbreaks in large flocks. As poultry farming becomes more intensive, businesses in animal husbandry are adopting early disease detection and regular health monitoring as essential strategies to prevent production losses and ensure the ongoing productivity of their flocks. Consequently, poultry farms, veterinary laboratories, and integrated poultry companies are increasingly using advanced diagnostic methods, such as PCR and ELISA, to quickly and accurately identify pathogens, including avian influenza, Newcastle disease, and infectious bronchitis.

Another significant factor driving demand is the heightened focus on biosafety, food security, and the control of regulated diseases throughout the global poultry supply chain. Governments, international organizations, and poultry farmers are enhancing their disease-tracking systems to prepare for major outbreaks that could result in substantial losses in meat and egg production and disrupt international trade. As a result, the use of diagnostics in poultry testing has become a common practice to facilitate safe access to production facilities and enable producers and veterinary authorities to implement timely containment measures while maintaining stable production levels.

Moreover, advancements in molecular diagnostics, automation, and mass testing capabilities have significantly improved the accuracy and efficiency of identifying poultry diseases. Innovations such as rapid PCR testing methods, robotic ELISA operations, portable diagnostic kits, and advanced sample processing are reducing response times and enabling large-scale testing of entire flocks. By leveraging these technological advancements, poultry producers and diagnostic laboratories can enhance their disease control strategies, ensuring optimal flock health monitoring and promoting ecological stability within modern poultry farming systems.

“By test type, the PCR-based diagnostics segment is projected to grow at the highest CAGR during the forecast period.”

The PCR-based diagnostics segment is expected to experience the highest growth in the poultry diagnostics market due to its high sensitivity and specificity, as well as its ability to quickly detect pathogens. PCR technology can identify even trace amounts of viral or bacterial genetic material. This capability allows for the detection of poultry diseases, such as avian influenza, Newcastle disease, and infectious bronchitis, at the pre-symptomatic stage, providing a timely opportunity for intervention. Intervening early helps limit the spread and impact of epidemics, reducing production losses. Additionally, the increasing demand for rapid, large-scale testing and improved disease monitoring in intensive poultry production systems is driving the widespread adoption of PCR-based diagnostics on commercial farms and in veterinary diagnostic laboratories.

“By sample type, the swabs segment accounted for the largest market share in 2025.”

In 2025, swabs led the poultry diagnostics market due to their ease of collection, non-invasive nature, and high reliability in detecting poultry pathogens. The two most common types of swab samples collected for diseases such as avian influenza, Newcastle disease, and infectious bronchitis are oropharyngeal and cloacal swabs. These swab samples are often used for disease surveillance and outbreak investigations. Swabs are the preferred sample type on poultry farms, in veterinary laboratories, and in surveillance programs because they are compatible with widely used diagnostic methods such as PCR and ELISA. Additionally, swabs facilitate sample collection from large flocks, making them ideal for large-scale testing and monitoring programs, which explains their extensive use in poultry disease diagnostics.

“The Asia Pacific region is expected to witness the highest growth rate during the forecast period.”

The Asia Pacific region is experiencing the fastest growth in the poultry diagnostics market. This growth can be attributed to several factors, including the rapid increase in poultry production, higher consumption rates, and the expansion of disease surveillance in major poultry-producing countries such as China, India, and various Southeast Asian nations. The region has faced multiple outbreaks of avian influenza and Newcastle disease, highlighting the importance of early detection and regular flock monitoring. Additionally, improvements in veterinary infrastructure and the rise of government initiatives for disease control and food safety are enabling poultry farms and veterinary laboratories in the region to adopt advanced diagnostic technologies more swiftly.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
• By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By End User: Veterinary Diagnostic Laboratories (45%), Integrated Poultry Producers (24%), Government & Reference Laboratories (14%), Academic & Research Institutions (10%), and Other Specialized Laboratories (7%)
• By Designation: Heads/Directors of Veterinary Diagnostic Laboratories (47%), Poultry Veterinarians/Technical Services Managers (22%), Animal Health Surveillance Officers (15%), and Others (16%)
• By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage

The market study covers the poultry diagnostics market in various segments. It aims to estimate the market size and growth potential by product type, test type, disease type, poultry type, sample type, end user, and region. The study also includes an in-depth competitive analysis of the market’s key players, along with their company profiles, key observations on their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

• Analysis of key drivers (rising incidence of transboundary & endemic diseases and growth in commercial & industrial poultry production), restraints (high cost of advanced molecular testing platforms and limited diagnostic infrastructure in developing regions), opportunities (geographic expansion in emerging poultry markets and development of rapid point-of-care (POC) tests), and challenges (rapid mutation and strain variability of viral pathogens and limited awareness among small & backyard farmers) influencing the growth of the poultry diagnostics market.
• Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the poultry diagnostics market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of poultry diagnostic products across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the poultry diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the poultry diagnostics market.

Table of Contents

1 INTRODUCTION 49
1.1 STUDY OBJECTIVES 49
1.2 MARKET DEFINITION 49
1.3 STUDY SCOPE 49
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 50
1.3.2 INCLUSIONS & EXCLUSIONS 51
1.3.3 YEARS CONSIDERED 52
1.4 MARKET STAKEHOLDERS 53
1.5 SUMMARY OF CHANGES 53
2 EXECUTIVE SUMMARY 55
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 55
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 56
2.3 DISRUPTIVE TRENDS IN POULTRY DIAGNOSTICS MARKET 57
2.4 HIGH-GROWTH SEGMENTS 58
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 59
3 PREMIUM INSIGHTS 60
3.1 POULTRY DIAGNOSTICS MARKET OVERVIEW 60
3.2 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE & COUNTRY (2025) 61
3.3 POULTRY DIAGNOSTICS MARKET: REGIONAL MIX 62
3.4 POULTRY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 63
3.5 POULTRY DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES 64
4 MARKET OVERVIEW 65
4.1 INTRODUCTION 65
4.2 MARKET DYNAMICS 65
4.2.1 DRIVERS 66
4.2.1.1 Rising incidence of transboundary and endemic diseases 66
4.2.1.2 Growth in commercial and industrial poultry production 66
4.2.1.3 Shift toward preventive flock health management 67
4.2.1.4 Technological advancements in molecular diagnostics,
multiplex assays, and rapid testing platforms 68
4.2.2 RESTRAINTS 68
4.2.2.1 High cost of advanced molecular diagnostic platforms and automated systems 68
4.2.2.2 Limited diagnostic infrastructure in developing regions 69
4.2.3 OPPORTUNITIES 70
4.2.3.1 Geographic expansion in emerging poultry markets 70
4.2.3.2 Expansion of rapid point-of-care and portable on-farm diagnostic solutions 70
4.2.4 CHALLENGES 71
4.2.4.1 Rapid mutation and strain variability of viral pathogens 71
4.2.4.2 Limited awareness among small & backyard farmers 71
4.3 UNMET NEEDS & WHITE SPACES 72
4.3.1 UNMET NEEDS IN POULTRY DIAGNOSTICS MARKET 72
4.3.2 WHITE SPACE OPPORTUNITIES 73
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 73
4.4.1 INTERCONNECTED MARKETS 73
4.4.2 CROSS-SECTOR OPPORTUNITIES 74
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 74
4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 74
5 INDUSTRY TRENDS 75
5.1 PORTER’S FIVE FORCES ANALYSIS 75
5.1.1 THREAT OF NEW ENTRANTS 76
5.1.2 THREAT OF SUBSTITUTES 76
5.1.3 BARGAINING POWER OF SUPPLIERS 76
5.1.4 BARGAINING POWER OF BUYERS 77
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 77
5.2 MACROECONOMIC INDICATORS 77
5.2.1 INTRODUCTION 77
5.2.2 GDP TRENDS & FORECAST 77
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 79
5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY 79
5.3 SUPPLY CHAIN ANALYSIS 79
5.4 VALUE CHAIN ANALYSIS 81
5.5 ECOSYSTEM ANALYSIS 82
5.6 PRICING ANALYSIS 83
5.6.1 AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS,
BY KEY PLAYER, 2023–2025 83
5.6.2 AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS,
BY REGION, 2023–2025 85
5.6.2.1 Average selling price trend of ELISA kits & reagents,
by region, 2023−2025 86
5.6.2.2 Average selling price trend of PCR reagents & kits,
by region, 2023−2025 86
5.6.2.3 Average selling price trend of sample preparation & extraction kits, by region, 2023−2025 86
5.6.2.4 Average selling price trend of controls & laboratory consumables,
by region, 2023−2025 87
5.6.2.5 Average selling price trend of PCR instruments,
by region, 2023−2025 87
5.6.2.6 Average selling price trend of ELISA readers & washers, by region, 2023−2025 87
5.6.2.7 Average selling price trend of nucleic acid extraction systems,
by region, 2023−2025 88
5.7 TRADE ANALYSIS 88
5.7.1 TRADE DATA FOR HS CODE 3822 89
5.7.1.1 Import data for HS Code 3822 89
5.7.1.2 Export data for HS Code 3822 89
5.8 KEY CONFERENCES & EVENTS, 2026–2027 90
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 91
5.10 INVESTMENT & FUNDING SCENARIO 91
5.11 SUCCESS STORIES & REAL-WORLD APPLICATIONS 92
5.11.1 AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION 92
5.11.2 MOLECULAR DETECTION AND CHARACTERIZATION OF AVIAN PATHOGENS USING MULTIPLEX PCR 93
5.11.3 MULTIPLEX PCR DETECTION OF RESPIRATORY PATHOGENS IN COMMERCIAL POULTRY FLOCKS 94
5.12 IMPACT OF 2025 US TARIFFS ON POULTRY DIAGNOSTICS MARKET 94
5.12.1 INTRODUCTION 94
5.12.2 KEY TARIFF RATES 96
5.12.3 PRICE IMPACT ANALYSIS 96
5.12.4 IMPACT ON COUNTRY/REGION 97
5.12.5 IMPACT ON END-USE INDUSTRIES 98
5.12.5.1 Veterinary diagnostic laboratories 98
5.12.5.2 Integrated poultry producers 98
5.12.5.3 Government & reference laboratories 99
5.12.5.4 Academic & research institutions 99
5.12.5.5 Other specialized laboratories 99
6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS,
AND DIGITAL & AI ADOPTION 100
6.1 TECHNOLOGY ANALYSIS 100
6.1.1 KEY EMERGING TECHNOLOGIES 100
6.1.1.1 CRISPR-based molecular diagnostics 100
6.1.1.2 Isothermal amplification and paper-based LAMP 100
6.1.2 COMPLEMENTARY TECHNOLOGIES 101
6.1.2.1 Environmental & wastewater surveillance 101
6.1.2.2 Microfluidic sensors 101
6.1.3 ADJACENT TECHNOLOGIES 102
6.1.3.1 AI & machine learning 102
6.1.3.2 Multiplex PCR panels 103

6.2 TECHNOLOGY/PRODUCT ROADMAP 103
6.2.1 NEAR TERM (2025–2027) 103
6.2.2 MID TERM (2028–2030) 104
6.2.3 LONG TERM (2030+) 104
6.3 PATENT ANALYSIS 104
6.3.1 PATENT PUBLICATION TRENDS FOR POULTRY DIAGNOSTICS 104
6.3.2 JURISDICTION & TOP APPLICANT ANALYSIS 105
6.4 FUTURE APPLICATIONS 107
6.4.1 PRECISION FLOCK-LEVEL DISEASE PREDICTION 107
6.4.2 MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS 108
6.4.3 CONTINUOUS ENVIRONMENTAL & WASTEWATER MONITORING SYSTEMS 108
6.4.4 MULTIPLEX & SYNDROMIC POULTRY DIAGNOSTIC PANELS 108
6.4.5 SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING 108
6.5 IMPACT OF AI/GENERATIVE AI ON POULTRY DIAGNOSTICS MARKET 108
6.5.1 INTRODUCTION 108
6.5.2 MARKET POTENTIAL IN POULTRY DIAGNOSTIC ECOSYSTEM 109
6.5.3 AI USE CASES 109
6.5.4 KEY COMPANIES IMPLEMENTING AI IN POULTRY DIAGNOSTICS MARKET 110
7 SUSTAINABILITY & REGULATORY LANDSCAPE 111
7.1 REGIONAL REGULATIONS & COMPLIANCE 111
7.1.1 REGULATORY ANALYSIS 111
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
7.1.3 INDUSTRY STANDARDS 113
7.2 SUSTAINABILITY INITIATIVES 114
7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR POULTRY DIAGNOSTIC PRODUCTS 114
7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 114
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 115
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 116
8.1 KEY STAKEHOLDERS & BUYING CRITERIA 116
8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 116
8.1.2 BUYING CRITERIA 117
8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 118
8.2.1 DECISION-MAKING PROCESS 118
8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 118
8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 119
8.2.4 MARKET PROFITABILITY 120

9 POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE 121
9.1 INTRODUCTION 122
9.2 CONSUMABLES & REAGENTS 124
9.2.1 ELISA KITS & REAGENTS 127
9.2.1.1 Large-scale serological surveillance and vaccination monitoring to sustain demand 127
9.2.1.2 Global volume analysis of ELISA kits & reagents, 2024–2031 (thousand units) 129
9.2.2 PCR KITS & REAGENTS 129
9.2.2.1 Rising adoption of molecular diagnostics to accelerate demand 129
9.2.2.2 Global volume analysis of PCR kits & reagents, 2024–2031 (thousand units) 132
9.2.3 SAMPLE PREPARATION & EXTRACTION KITS 132
9.2.3.1 Increasing use of molecular testing to fuel market growth 132
9.2.3.2 Global volume analysis of sample preparation & extraction kits, 2024–2031 (thousand units) 134
9.2.4 CONTROLS & LABORATORY CONSUMABLES 135
9.2.4.1 Expanding diagnostic test volumes to drive consistent demand 135
9.2.4.2 Global volume analysis of controls & laboratory consumables,
2024–2031 (thousand units) 137
9.3 INSTRUMENTS 137
9.3.1 PCR INSTRUMENTS 140
9.3.1.1 Growing need for rapid and high-sensitivity pathogen detection to boost market 140
9.3.1.2 Global volume analysis of PCR instruments, 2024–2031 (thousand units) 142
9.3.2 ELISA READERS & WASHERS 142
9.3.2.1 High-throughput serological testing to support continued use of ELISA readers 142
9.3.2.2 Global volume analysis of ELISA readers & washers,
2024–2031 (thousand units) 144
9.3.3 NUCLEIC ACID EXTRACTION SYSTEMS 144
9.3.3.1 Rising molecular testing workflows to drive adoption 144
9.3.3.2 Global volume analysis of nucleic acid extraction systems,
2024–2031 (thousand units) 146
9.3.4 OTHER LABORATORY AUTOMATION INSTRUMENTS 147
9.3.4.1 Global volume analysis of other laboratory automation instruments, 2024–2031 (thousand units) 148
10 POULTRY DIAGNOSTICS MARKET, BY TEST TYPE 149
10.1 INTRODUCTION 150
10.2 PCR-BASED DIAGNOSTICS 151
10.2.1 AVIAN INFLUENZA PCR PANELS 154
10.2.1.1 Global surveillance programs and outbreak monitoring to boost demand 154
10.2.1.2 Global volume analysis of avian influenza PCR panels,
2024–2031 (thousand tests) 156
10.2.1.3 Global volume analysis of avian influenza PCR panels,
2024–2031 (thousand animals) 157
10.2.2 NEWCASTLE DISEASE PCR PANELS 157
10.2.2.1 High transmissibility of Newcastle disease to increase reliance on molecular PCR detection 157
10.2.2.2 Global volume analysis of Newcastle disease PCR panels,
2024–2031 (thousand tests) 159
10.2.2.3 Global volume analysis of Newcastle disease PCR panels,
2024–2031 (thousand animals) 160
10.2.3 ENDEMIC VIRAL PCR PANELS 160
10.2.3.1 Routine flock health monitoring to accelerate use of multiplex endemic viral PCR panels 160
10.2.3.2 Global volume analysis of endemic viral PCR panels,
2024–2031 (thousand tests) 162
10.2.3.3 Global volume analysis of endemic viral PCR panels,
2024–2031 (thousand animals) 163
10.2.4 MYCOPLASMA PCR PANELS 163
10.2.4.1 Need for early identification of mycoplasma infections to drive adoption 163
10.2.4.2 Global volume analysis of Mycoplasma PCR panels,
2024–2031 (thousand tests) 166
10.2.4.3 Global volume analysis of Mycoplasma PCR panels,
2024–2031 (thousand animals) 166
10.2.5 BACTERIAL PCR PANELS 167
10.2.5.1 Increasing focus on pathogen detection and food safety to support market growth 167
10.2.5.2 Global volume analysis of bacterial PCR panels,
2024–2031 (thousand tests) 169
10.2.5.3 Global volume analysis of bacterial PCR panels,
2024–2031 (thousand animals) 169
10.3 ELISA-BASED DIAGNOSTICS 170
10.3.1 ENDEMIC VIRAL ELISA TESTS 173
10.3.1.1 Routine immunity monitoring in poultry flocks to drive demand 173
10.3.1.2 Global volume analysis of endemic viral ELISA tests,
2024–2031 (thousand tests) 175
10.3.1.3 Global volume analysis of endemic viral ELISA tests,
2024–2031 (thousand animals) 175
10.3.2 AVIAN INFLUENZA ELISA TESTS 176
10.3.2.1 Large-scale serological surveillance programs to support use of avian influenza ELISA assays 176
10.3.2.2 Global volume analysis of avian influenza ELISA tests,
2024–2031 (thousand tests) 178
10.3.2.3 Global volume analysis of avian influenza ELISA tests,
2024–2031 (thousand animals) 178

10.3.3 NEWCASTLE DISEASE ELISA TESTS 179
10.3.3.1 Vaccination monitoring and flock immunity assessment to fuel demand 179
10.3.3.2 Global volume analysis of Newcastle disease ELISA tests,
2024–2031 (thousand tests) 181
10.3.3.3 Global volume analysis of Newcastle disease ELISA tests,
2024–2031 (thousand animals) 181
10.3.4 MYCOPLASMA ELISA TESTS 182
10.3.4.1 Ongoing flock health surveillance to increase adoption of mycoplasma ELISA testing 182
10.3.4.2 Global volume analysis of mycoplasma ELISA tests,
2024–2031 (thousand tests) 184
10.3.4.3 Global volume analysis of mycoplasma ELISA tests,
2024–2031 (thousand animals) 184
10.3.5 BACTERIAL ELISA TESTS 185
10.3.5.1 Growing emphasis on bacterial disease control to support use of bacterial ELISA diagnostics 185
10.3.5.2 Global volume analysis of bacterial ELISA tests,
2024–2031 (thousand tests) 187
10.3.5.3 Global volume analysis of bacterial ELISA tests,
2024–2031 (thousand animals) 187
10.4 OTHER DIAGNOSTIC TESTS 188
11 POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE 190
11.1 INTRODUCTION 191
11.2 AVIAN INFLUENZA 191
11.2.1 GLOBAL SURVEILLANCE PROGRAMS AND FREQUENT HPAI OUTBREAKS TO DRIVE DEMAND 191
11.3 NEWCASTLE DISEASE 194
11.3.1 HIGH CONTAGIOUSNESS AND ONGOING OUTBREAK RISKS TO FUEL MARKET GROWTH 194
11.4 INFECTIOUS BRONCHITIS 196
11.4.1 EMERGENCE OF MULTIPLE IBV VARIANTS TO INCREASE DEMAND FOR DIAGNOSTICS 196
11.5 AVIAN MYCOPLASMOSIS 198
11.5.1 RISING FOCUS ON RESPIRATORY DISEASE CONTROL TO BOOST ADOPTION 198
11.6 SALMONELLOSIS 200
11.6.1 INCREASING FOOD SAFETY REGULATIONS AND SURVEILLANCE PROGRAMS TO BOOST MARKET GROWTH 200
11.7 INFECTIOUS BURSAL DISEASE 203
11.7.1 NEED TO MONITOR IMMUNOSUPPRESSIVE VIRAL INFECTIONS TO DRIVE DEMAND 203
11.8 OTHER INFECTIOUS DISEASES 205

12 POULTRY DIAGNOSTICS MARKET, BY POULTRY TYPE 208
12.1 INTRODUCTION 209
12.2 PCR-BASED DIAGNOSTICS 209
12.2.1 BROILERS 210
12.2.1.1 High-density meat production systems to drive strong adoption of PCR testing 210
12.2.2 LAYERS 212
12.2.2.1 Need for rapid detection of diseases affecting egg production to support market growth 212
12.2.3 BREEDERS 213
12.2.3.1 Prevention of vertical pathogen transmission to drive extensive PCR surveillance 213
12.2.4 TURKEYS 215
12.2.4.1 Disease monitoring in commercial turkey production to support adoption 215
12.2.5 DUCKS & GEESE 216
12.2.5.1 Role of waterfowl in avian influenza surveillance to increase PCR testing 216
12.2.6 OTHER POULTRY 218
12.3 ELISA-BASED DIAGNOSTICS 219
12.3.1 BROILERS 220
12.3.1.1 Monitoring vaccine-induced immunity to drive ELISA-based serological testing 220
12.3.2 LAYERS 222
12.3.2.1 Long production cycles and egg yield monitoring to support market growth 222
12.3.3 BREEDERS 223
12.3.3.1 Routine antibody monitoring for disease-free breeding programs to drive ELISA testing 223
12.3.4 TURKEYS 225
12.3.4.1 Need for effective vaccination monitoring to support ELISA-based diagnostics 225
12.3.5 DUCKS & GEESE 226
12.3.5.1 Serological surveillance of waterfowl populations to boost market growth 226
12.3.6 OTHER POULTRY 228
12.4 OTHER DIAGNOSTIC TESTS 229
12.4.1 BROILERS 230
12.4.1.1 Rapid screening and confirmatory testing to require conventional diagnostics 230
12.4.2 LAYERS 232
12.4.2.1 Long-term flock monitoring to drive continued use of traditional diagnostic tests 232

12.4.3 BREEDERS 233
12.4.3.1 Established serological methods to support disease surveillance in breeder flocks 233
12.4.4 TURKEYS 235
12.4.4.1 Routine disease screening and pathogen identification to sustain use of conventional diagnostics 235
12.4.5 DUCKS & GEESE 236
12.4.5.1 Surveillance of waterfowl-associated pathogens to maintain use of traditional diagnostic methods 236
12.4.6 OTHER POULTRY 238
13 POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE 240
13.1 INTRODUCTION 241
13.2 SWABS 241
13.2.1 EASE OF COLLECTION AND SUITABILITY FOR MOLECULAR TESTING TO DRIVE WIDESPREAD USE OF SWAB SAMPLES 241
13.3 SERUM/BLOOD 243
13.3.1 GROWING FOCUS ON FLOCK IMMUNITY MONITORING AND VACCINATION ASSESSMENT TO SUPPORT DEMAND 243
13.4 TISSUE SAMPLES 244
13.4.1 NEED FOR CONFIRMATORY DIAGNOSIS AND DETAILED PATHOLOGICAL INVESTIGATION TO DRIVE MARKET GROWTH 244
13.5 ENVIRONMENTAL & FECAL SAMPLES 246
13.5.1 RISING EMPHASIS ON FARM-LEVEL SURVEILLANCE AND BIOSECURITY MONITORING TO BOOST ADOPTION 246
14 POULTRY DIAGNOSTICS MARKET, BY END USER 248
14.1 INTRODUCTION 249
14.2 VETERINARY DIAGNOSTIC LABORATORIES 249
14.2.1 CENTRAL ROLE IN DISEASE SURVEILLANCE AND HIGH TESTING VOLUMES TO DRIVE DEMAND 249
14.3 INTEGRATED POULTRY PRODUCERS 251
14.3.1 GROWING VERTICAL INTEGRATION AND NEED FOR CONTINUOUS FLOCK MONITORING TO INCREASE DIAGNOSTIC ADOPTION 251
14.4 GOVERNMENT & REFERENCE LABORATORIES 253
14.4.1 NATIONAL DISEASE SURVEILLANCE PROGRAMS AND REGULATORY TESTING REQUIREMENTS TO BOOST MARKET GROWTH 253
14.5 ACADEMIC & RESEARCH INSTITUTIONS 254
14.5.1 RISING RESEARCH ON POULTRY PATHOGENS AND DIAGNOSTIC INNOVATION TO SUPPORT DEMAND 254
14.6 OTHER SPECIALIZED LABORATORIES 256
14.6.1 INCREASING OUTSOURCING OF ADVANCED TESTING SERVICES TO DRIVE DEMAND 256

15 POULTRY DIAGNOSTICS MARKET, BY REGION 258
15.1 INTRODUCTION 259
15.2 NORTH AMERICA 260
15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 261
15.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 262
15.2.3 NORTH AMERICA: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 263
15.2.4 US 270
15.2.4.1 Large-scale poultry production to drive demand for poultry diagnostic testing 270
15.2.5 CANADA 277
15.2.5.1 Strong biosecurity regulations and expanding poultry production to drive market 277
15.3 EUROPE 284
15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 284
15.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 285
15.3.3 EUROPE: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 286
15.3.4 GERMANY 293
15.3.4.1 Germany to dominate European market during forecast period 293
15.3.5 UK 299
15.3.5.1 Robust disease surveillance programs to drive market growth 299
15.3.6 FRANCE 305
15.3.6.1 Frequent avian influenza outbreaks and large poultry production systems to fuels market growth 305
15.3.7 ITALY 311
15.3.7.1 Growing poultry production to support market growth 311
15.3.8 SPAIN 317
15.3.8.1 Expanding broiler production and increasing disease surveillance to drive market growth 317
15.3.9 NETHERLANDS 323
15.3.9.1 Advanced veterinary surveillance infrastructure to drive market growth 323
15.3.10 POLAND 330
15.3.10.1 Rapid expansion of poultry production and export-oriented farming to increase demand 330
15.3.11 RUSSIA 336
15.3.11.1 Expanding domestic poultry production to drive market growth 336
15.3.12 REST OF EUROPE 342
15.4 ASIA PACIFIC 348
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 348
15.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 350
15.4.3 ASIA PACIFIC: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 351
15.4.4 CHINA 359
15.4.4.1 China to dominate APAC market during forecast period 359
15.4.5 JAPAN 365
15.4.5.1 Recurring avian influenza outbreaks to drive market 365
15.4.6 INDIA 371
15.4.6.1 Rapidly expanding poultry industry and increasing disease surveillance initiatives to boost market growth 371
15.4.7 AUSTRALIA 377
15.4.7.1 Strong biosecurity regulations and advanced poultry production systems to support market growth 377
15.4.8 SOUTH KOREA 383
15.4.8.1 Frequent avian influenza outbreaks and intensive poultry farming to boost market growth 383
15.4.9 THAILAND 389
15.4.9.1 Export-oriented poultry production to drive market 389
15.4.10 NEW ZEALAND 395
15.4.10.1 Strict biosecurity systems and preventive disease surveillance programs to support market growth 395
15.4.11 INDONESIA 401
15.4.11.1 Large poultry population to fuel market growth 401
15.4.12 PHILIPPINES 407
15.4.12.1 Expanding poultry production and rising disease monitoring efforts to drive adoption 407
15.4.13 REST OF ASIA PACIFIC 413
15.5 LATIN AMERICA 420
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 420
15.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 421
15.5.3 LATIN AMERICA: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 422
15.5.4 BRAZIL 429
15.5.4.1 Large-scale poultry production and export-driven poultry industry to drive demand 429
15.5.5 MEXICO 435
15.5.5.1 Strong domestic poultry consumption to contribute to market growth 435
15.5.6 ARGENTINA 441
15.5.6.1 Expanding poultry production and increased disease monitoring to drive market 441
15.5.7 REST OF LATIN AMERICA 447
15.6 MIDDLE EAST & AFRICA 454
15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 454
15.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 455
15.6.3 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 456
15.6.4 GCC COUNTRIES 463
15.6.4.1 Kingdom of Saudi Arabia (KSA) 469
15.6.4.1.1 Expanding domestic poultry production and national food security initiatives to boost growth 469
15.6.4.2 United Arab Emirates (UAE) 475
15.6.4.2.1 Increasing investments in poultry farming to fuel UAE’s market growth 475
15.6.4.3 Rest of GCC Countries 481
15.6.5 REST OF MIDDLE EAST & AFRICA 487
16 COMPETITIVE LANDSCAPE 494
16.1 OVERVIEW 494
16.2 KEY PLAYER STRATEGY/RIGHT TO WIN 494
16.3 REVENUE ANALYSIS, 2021−2025 496
16.4 MARKET SHARE ANALYSIS, 2025 497
16.4.1 US MARKET SHARE ANALYSIS, 2025 498
16.4.2 EUROPE MARKET SHARE ANALYSIS, 2025 499
16.4.3 RANKING OF KEY MARKET PLAYERS 500
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 502
16.5.1 STARS 502
16.5.2 EMERGING LEADERS 502
16.5.3 PERVASIVE PLAYERS 502
16.5.4 PARTICIPANTS 502
16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 504
16.5.5.1 Company footprint 504
16.5.5.2 Region footprint 505
16.5.5.3 Product type footprint 506
16.5.5.4 Test type footprint 507
16.5.5.5 Disease type footprint 508
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 509
16.6.1 PROGRESSIVE COMPANIES 509
16.6.2 RESPONSIVE COMPANIES 509
16.6.3 DYNAMIC COMPANIES 509
16.6.4 STARTING BLOCKS 509
16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 511
16.6.5.1 Detailed list of key startups/SMEs 511
16.6.5.2 Competitive benchmarking of key startups 512
16.7 BRAND/PRODUCT COMPARISON 513
16.8 R&D EXPENDITURE OF KEY PLAYERS 513
16.9 COMPANY VALUATION & FINANCIAL METRICS 514
16.9.1 FINANCIAL METRICS 514
16.9.2 COMPANY VALUATION 514
16.10 COMPETITIVE SCENARIO 515
16.10.1 PRODUCT LAUNCHES 515
16.10.2 DEALS 515
16.10.3 EXPANSIONS 516
16.10.4 OTHER DEVELOPMENTS 517
17 COMPANY PROFILES 518
17.1 KEY PLAYERS 518
17.1.1 IDEXX LABORATORIES, INC. 518
17.1.1.1 Business overview 518
17.1.1.2 Products offered 519
17.1.1.3 MnM view 521
17.1.1.3.1 Key strengths 521
17.1.1.3.2 Strategic choices 521
17.1.1.3.3 Weaknesses & competitive threats 521
17.1.2 THERMO FISHER SCIENTIFIC INC. 522
17.1.2.1 Business overview 522
17.1.2.2 Products offered 524
17.1.2.3 MnM view 525
17.1.2.3.1 Key strengths 525
17.1.2.3.2 Strategic choices 525
17.1.2.3.3 Weaknesses & competitive threats 525
17.1.3 ZOETIS SERVICES LLC 526
17.1.3.1 Business overview 526
17.1.3.2 Products offered 528
17.1.3.3 Recent developments 528
17.1.3.3.1 Deals 528
17.1.3.3.2 Expansions 529
17.1.3.3.3 Other developments 529
17.1.3.4 MnM view 530
17.1.3.4.1 Key strengths 530
17.1.3.4.2 Strategic choices 530
17.1.3.4.3 Weaknesses & competitive threats 530
17.1.4 BIOCHEK 531
17.1.4.1 Business overview 531
17.1.4.2 Products offered 531
17.1.4.3 Recent developments 533
17.1.4.3.1 Product launches 533
17.1.4.3.2 Deals 534
17.1.4.4 MnM view 534
17.1.4.4.1 Key strengths 534
17.1.4.4.2 Strategic choices 534
17.1.4.4.3 Weaknesses & competitive threats 535

17.1.5 INNOVATIVE DIAGNOSTICS 536
17.1.5.1 Business overview 536
17.1.5.2 Products offered 536
17.1.5.3 Recent developments 539
17.1.5.3.1 Other developments 539
17.1.5.4 MnM view 540
17.1.5.4.1 Key strengths 540
17.1.5.4.2 Strategic choices 540
17.1.5.4.3 Weaknesses & competitive threats 540
17.1.6 BIONOTE 541
17.1.6.1 Business overview 541
17.1.6.2 Products offered 541
17.1.6.3 Recent developments 542
17.1.6.3.1 Deals 542
17.1.7 BIO-RAD LABORATORIES, INC. 543
17.1.7.1 Business overview 543
17.1.7.2 Products offered 544
17.1.8 GD 545
17.1.8.1 Business overview 545
17.1.8.2 Products offered 545
17.1.8.3 Recent developments 548
17.1.8.3.1 Product launches 548
17.1.8.3.2 Deals 548
17.1.8.3.3 Expansions 548
17.1.8.3.4 Other developments 549
17.1.9 INDICAL BIOSCIENCE GMBH 550
17.1.9.1 Business overview 550
17.1.9.2 Products offered 551
17.1.9.3 Recent developments 552
17.1.9.3.1 Product enhancements 552
17.1.10 SHENZHEN BIOEASY BIOTECHNOLOGY, INC. 553
17.1.10.1 Business overview 553
17.1.10.2 Products offered 553
17.1.11 RING BIOTECHNOLOGY CO., LTD. 554
17.1.11.1 Business overview 554
17.1.11.2 Products offered 555
17.1.11.3 Recent developments 556
17.1.11.3.1 Product launches 556
17.1.12 BIO-X DIAGNOSTICS S.A. 557
17.1.12.1 Business overview 557
17.1.12.2 Products offered 557

17.1.13 MEGACOR DIAGNOSTIK GMBH 559
17.1.13.1 Business overview 559
17.1.13.2 Products offered 560
17.1.14 GOLD STANDARD DIAGNOSTICS 562
17.1.14.1 Business overview 562
17.1.14.2 Products offered 562
17.1.14.2.1 Other developments 564
17.1.15 BIONEER CORPORATION 565
17.1.15.1 Business overview 565
17.1.15.2 Products offered 566
17.2 OTHER PLAYERS 567
17.2.1 ELABSCIENCE, INC. 567
17.2.2 BIOSELLAL 568
17.2.3 BIOGAL 569
17.2.4 BIOSTONE ANIMAL HEALTH 570
17.2.5 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD. 574
17.2.6 ABBEXA 575
17.2.7 BIOINGENTECH 576
17.2.8 AFFIGEN INC. 579
17.2.9 ALVEO TECHNOLOGIES 580
17.2.10 HIMEDIA LABORATORIES 581
18 RESEARCH METHODOLOGY 582
18.1 RESEARCH DATA 582
18.2 RESEARCH METHODOLOGY DESIGN 582
18.2.1 SECONDARY DATA 583
18.2.1.1 Key data from secondary sources 584
18.2.2 PRIMARY DATA 584
18.2.2.1 Key data from primary sources 585
18.2.2.2 Key industry insights 586
18.3 MARKET SIZE ESTIMATION 587
18.3.1 BOTTOM-UP APPROACH 595
18.4 MARKET BREAKDOWN & DATA TRIANGULATION 596
18.5 MARKET SHARE ANALYSIS 597
18.5.1 RESEARCH ASSUMPTIONS 597
18.5.2 GROWTH RATE ASSUMPTIONS 597
18.6 RISK ASSESSMENT 598
18.7 RESEARCH LIMITATIONS 598
18.7.1 METHODOLOGY-RELATED LIMITATIONS 598
18.7.2 SCOPE-RELATED LIMITATIONS 598

19 APPENDIX 599
19.1 DISCUSSION GUIDE 599
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 605
19.3 CUSTOMIZATION OPTIONS 607
19.3.1 PRODUCT ANALYSIS 607
19.3.2 COMPANY INFORMATION 607
19.3.3 GEOGRAPHIC ANALYSIS 607
19.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 607
19.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT TYPE 607
19.3.6 MARKET SHARE ANALYSIS, BY PRODUCT TYPE (TOP 5 PLAYERS) 607
19.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 607
19.4 RELATED REPORTS 608
19.5 AUTHOR DETAILS 609

LIST OF TABLES

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 52
TABLE 2 POULTRY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 75
TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 78
TABLE 4 AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS,
BY KEY PLAYER, 2023–2025 84
TABLE 5 AVERAGE SELLING PRICE TREND OF ELISA KITS & REAGENTS,
BY REGION, 2023−2025 86
TABLE 6 AVERAGE SELLING PRICE TREND OF PCR REAGENTS & KITS,
BY REGION, 2023−2025 86
TABLE 7 AVERAGE SELLING PRICE TREND OF SAMPLE PREPARATION & EXTRACTION KITS, BY REGION, 2023−2025 86
TABLE 8 AVERAGE SELLING PRICE TREND OF CONTROLS & LABORATORY CONSUMABLES, BY REGION, 2023−2025 87
TABLE 9 AVERAGE SELLING PRICE TREND OF PCR INSTRUMENTS, BY REGION, 2023−2025 87
TABLE 10 AVERAGE SELLING PRICE TREND OF ELISA READERS & WASHERS,
BY REGION, 2023−2025 87
TABLE 11 AVERAGE SELLING PRICE TREND OF NUCLEIC ACID EXTRACTION SYSTEMS,
BY REGION, 2023−2025 88
TABLE 12 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021–2025 (USD THOUSAND) 89
TABLE 13 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021–2025 (USD THOUSAND) 89
TABLE 14 POULTRY DIAGNOSTICS MARKET: MAJOR CONFERENCES & EVENTS
IN 2026–2027 90
TABLE 15 CASE STUDY 1: AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION 92
TABLE 16 CASE STUDY 2: MOLECULAR DETECTION AND CHARACTERIZATION OF AVIAN PATHOGENS USING MULTIPLEX PCR 93
TABLE 17 CASE STUDY 3: MULTIPLEX PCR DETECTION OF RESPIRATORY PATHOGENS IN COMMERCIAL POULTRY FLOCKS 94
TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES 96
TABLE 19 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR POULTRY DIAGNOSTIC PRODUCTS 96
TABLE 20 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 97
TABLE 21 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 97
TABLE 22 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 98
TABLE 23 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 98
TABLE 24 POULTRY DIAGNOSTICS MARKET: MAJOR PATENTS 106
TABLE 25 KEY COMPANIES IMPLEMENTING AI IN POULTRY DIAGNOSTICS MARKET 110
TABLE 26 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 111
TABLE 27 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 112
TABLE 28 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 113
TABLE 29 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR POULTRY DIAGNOSTIC PRODUCTS 116
TABLE 30 KEY BUYING CRITERIA FOR TOP THREE END USERS 117
TABLE 31 POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 122
TABLE 32 POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 33 KEY PLAYERS PROVIDING CONSUMABLES & REAGENTS 124
TABLE 34 POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 125
TABLE 35 POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 36 KEY PLAYERS PROVIDING ELISA KITS & REAGENTS 127
TABLE 37 POULTRY DIAGNOSTICS MARKET FOR ELISA KITS & REAGENTS,
BY COUNTRY, 2024–2031 (USD MILLION) 128
TABLE 38 POULTRY DIAGNOSTICS MARKET FOR ELISA KITS & REAGENTS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 129
TABLE 39 KEY PLAYERS PROVIDING PCR KITS & REAGENTS 130
TABLE 40 POULTRY DIAGNOSTICS MARKET FOR PCR KITS & REAGENTS,
BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 41 POULTRY DIAGNOSTICS MARKET FOR PCR KITS & REAGENTS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 132
TABLE 42 KEY PLAYERS PROVIDING SAMPLE PREPARATION & EXTRACTION KITS 133
TABLE 43 POULTRY DIAGNOSTICS MARKET FOR SAMPLE PREPARATION & EXTRACTION KITS, BY COUNTRY, 2024–2031 (USD MILLION) 133
TABLE 44 POULTRY DIAGNOSTICS MARKET FOR SAMPLE PREPARATION & EXTRACTION KITS, BY TYPE, 2024–2031 (THOUSAND UNITS) 134
TABLE 45 KEY PLAYERS PROVIDING CONTROLS & LABORATORY CONSUMABLES 135
TABLE 46 POULTRY DIAGNOSTICS MARKET FOR CONTROLS & LABORATORY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 136
TABLE 47 POULTRY DIAGNOSTICS MARKET FOR CONTROLS & LABORATORY CONSUMABLES, BY TYPE, 2024–2031 (THOUSAND UNITS) 137
TABLE 48 KEY PLAYERS PROVIDING INSTRUMENTS 138
TABLE 49 POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 138
TABLE 50 POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 51 KEY PLAYERS PROVIDING PCR INSTRUMENTS 140
TABLE 52 POULTRY DIAGNOSTICS MARKET FOR PCR INSTRUMENTS,
BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 53 POULTRY DIAGNOSTICS MARKET FOR PCR INSTRUMENTS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 142
TABLE 54 KEY PLAYERS PROVIDING ELISA READERS & WASHERS 143
TABLE 55 POULTRY DIAGNOSTICS MARKET FOR ELISA READERS & WASHERS,
BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 56 POULTRY DIAGNOSTICS MARKET FOR ELISA READERS & WASHERS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 144
TABLE 57 KEY PLAYERS PROVIDING NUCLEIC ACID EXTRACTION SYSTEMS 145
TABLE 58 POULTRY DIAGNOSTICS MARKET FOR NUCLEIC ACID EXTRACTION SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 59 POULTRY DIAGNOSTICS MARKET FOR NUCLEIC ACID EXTRACTION SYSTEMS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 146
TABLE 60 POULTRY DIAGNOSTICS MARKET FOR OTHER LABORATORY AUTOMATION INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 61 POULTRY DIAGNOSTICS MARKET FOR OTHER LABORATORY AUTOMATION INSTRUMENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 148
TABLE 62 POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 150
TABLE 63 KEY PLAYERS PROVIDING PCR-BASED DIAGNOSTICS 151
TABLE 64 POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 153
TABLE 65 POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 66 KEY PLAYERS PROVIDING AVIAN INFLUENZA PCR PANELS 155
TABLE 67 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA PCR PANELS,
BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 68 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 156
TABLE 69 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 157
TABLE 70 KEY PLAYERS PROVIDING NEWCASTLE DISEASE PCR PANELS 158
TABLE 71 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE PCR PANELS,
BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 72 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 159
TABLE 73 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 160
TABLE 74 KEY PLAYERS PROVIDING ENDEMIC VIRAL PCR PANELS 161
TABLE 75 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL PCR PANELS,
BY COUNTRY, 2024–2031 (USD MILLION) 161
TABLE 76 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 162
TABLE 77 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 163
TABLE 78 KEY PLAYERS PROVIDING MYCOPLASMA PCR PANELS 164
TABLE 79 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA PCR PANELS,
BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 80 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 166
TABLE 81 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 166
TABLE 82 KEY PLAYERS PROVIDING BACTERIAL PCR PANELS 167
TABLE 83 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL PCR PANELS,
BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 84 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 169
TABLE 85 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL PCR PANELS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 169
TABLE 86 KEY PLAYERS PROVIDING ELISA-BASED DIAGNOSTICS 170
TABLE 87 POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 171
TABLE 88 POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 89 KEY PLAYERS PROVIDING ENDEMIC VIRAL ELISA TESTS 173
TABLE 90 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL ELISA TESTS,
BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 91 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 175
TABLE 92 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 175
TABLE 93 KEY PLAYERS PROVIDING AVIAN INFLUENZA ELISA TESTS 176
TABLE 94 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA ELISA TESTS,
BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 95 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 178
TABLE 96 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 178
TABLE 97 KEY PLAYERS PROVIDING NEWCASTLE DISEASE ELISA TESTS 179
TABLE 98 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE ELISA TESTS,
BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 99 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 181
TABLE 100 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 181
TABLE 101 KEY PLAYERS PROVIDING MYCOPLASMA ELISA TESTS 182
TABLE 102 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA ELISA TESTS,
BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 103 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 184
TABLE 104 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 184
TABLE 105 KEY PLAYERS PROVIDING BACTERIAL ELISA TESTS 185
TABLE 106 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL ELISA TESTS,
BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 107 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 187
TABLE 108 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL ELISA TESTS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 187
TABLE 109 KEY PLAYERS PROVIDING OTHER DIAGNOSTIC TESTS 188
TABLE 110 POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY COUNTRY, 2024–2031 (USD MILLION) 189
TABLE 111 POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 191
TABLE 112 KEY PLAYERS PROVIDING AVIAN INFLUENZA DIAGNOSTIC PRODUCTS 192
TABLE 113 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA,
BY COUNTRY, 2024–2031 (USD MILLION) 193
TABLE 114 KEY PLAYERS PROVIDING NEWCASTLE DISEASE DIAGNOSTIC PRODUCTS 194
TABLE 115 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE,
BY COUNTRY, 2024–2031 (USD MILLION) 195
TABLE 116 KEY PLAYERS PROVIDING INFECTIOUS BRONCHITIS DIAGNOSTIC PRODUCTS 197
TABLE 117 POULTRY DIAGNOSTICS MARKET FOR INFECTIOUS BRONCHITIS,
BY COUNTRY, 2024–2031 (USD MILLION) 197
TABLE 118 KEY PLAYERS PROVIDING AVIAN MYCOPLASMOSIS DIAGNOSTIC PRODUCTS 199
TABLE 119 POULTRY DIAGNOSTICS MARKET FOR AVIAN MYCOPLASMOSIS,
BY COUNTRY, 2024–2031 (USD MILLION) 199
TABLE 120 KEY PLAYERS PROVIDING SALMONELLOSIS DIAGNOSTIC PRODUCTS 201
TABLE 121 POULTRY DIAGNOSTICS MARKET FOR SALMONELLOSIS, BY COUNTRY,
2024–2031 (USD MILLION) 202
TABLE 122 KEY PLAYERS PROVIDING INFECTIOUS BURSAL DISEASE DIAGNOSTIC PRODUCTS 204
TABLE 123 POULTRY DIAGNOSTICS MARKET FOR INFECTIOUS BURSAL DISEASE,
BY COUNTRY, 2024–2031 (USD MILLION) 204
TABLE 124 KEY PLAYERS PROVIDING OTHER INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS 206
TABLE 125 POULTRY DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASES,
BY COUNTRY, 2024–2031 (USD MILLION) 207
TABLE 126 POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 210
TABLE 127 PCR-BASED DIAGNOSTICS MARKET FOR BROILERS, BY COUNTRY,
2024–2031 (USD MILLION) 211
TABLE 128 PCR-BASED DIAGNOSTICS MARKET FOR LAYERS, BY COUNTRY,
2024–2031 (USD MILLION) 212
TABLE 129 PCR-BASED DIAGNOSTICS MARKET FOR BREEDERS, BY COUNTRY,
2024–2031 (USD MILLION) 214
TABLE 130 PCR-BASED DIAGNOSTICS MARKET FOR TURKEYS, BY COUNTRY,
2024–2031 (USD MILLION) 215
TABLE 131 PCR-BASED DIAGNOSTICS MARKET FOR DUCKS & GEESE,
BY COUNTRY, 2024–2031 (USD MILLION) 217
TABLE 132 PCR-BASED DIAGNOSTICS MARKET FOR OTHER POULTRY,
BY COUNTRY, 2024–2031 (USD MILLION) 218
TABLE 133 POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 220
TABLE 134 ELISA-BASED DIAGNOSTICS MARKET FOR BROILERS,
BY COUNTRY, 2024–2031 (USD MILLION) 221
TABLE 135 ELISA-BASED DIAGNOSTICS MARKET FOR LAYERS,
BY COUNTRY, 2024–2031 (USD MILLION) 222
TABLE 136 ELISA-BASED DIAGNOSTICS MARKET FOR BREEDERS,
BY COUNTRY, 2024–2031 (USD MILLION) 224
TABLE 137 ELISA-BASED DIAGNOSTICS MARKET FOR TURKEYS,
BY COUNTRY, 2024–2031 (USD MILLION) 225
TABLE 138 ELISA-BASED DIAGNOSTICS MARKET FOR DUCKS & GEESE,
BY COUNTRY, 2024–2031 (USD MILLION) 227
TABLE 139 ELISA-BASED DIAGNOSTICS MARKET FOR OTHER POULTRY,
BY COUNTRY, 2024–2031 (USD MILLION) 228
TABLE 140 POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 230
TABLE 141 OTHER DIAGNOSTIC TESTS MARKET FOR BROILERS, BY COUNTRY,
2024–2031 (USD MILLION) 231
TABLE 142 OTHER DIAGNOSTIC TESTS MARKET FOR LAYERS, BY COUNTRY,
2024–2031 (USD MILLION) 232
TABLE 143 OTHER DIAGNOSTIC TESTS MARKET FOR BREEDERS, BY COUNTRY,
2024–2031 (USD MILLION) 234
TABLE 144 OTHER DIAGNOSTIC TESTS MARKET FOR TURKEYS, BY COUNTRY,
2024–2031 (USD MILLION) 235
TABLE 145 OTHER DIAGNOSTIC TESTS MARKET FOR DUCKS & GEESE,
BY COUNTRY, 2024–2031 (USD MILLION) 237
TABLE 146 OTHER DIAGNOSTIC TESTS MARKET FOR OTHER POULTRY,
BY COUNTRY, 2024–2031 (USD MILLION) 239
TABLE 147 POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 241
TABLE 148 POULTRY DIAGNOSTICS MARKET FOR SWABS, BY COUNTRY,
2024–2031 (USD MILLION) 242
TABLE 149 POULTRY DIAGNOSTICS MARKET FOR SERUM/BLOOD,
BY COUNTRY, 2024–2031 (USD MILLION) 243
TABLE 150 POULTRY DIAGNOSTICS MARKET FOR TISSUE SAMPLES,
BY COUNTRY, 2024–2031 (USD MILLION) 245
TABLE 151 POULTRY DIAGNOSTICS MARKET FOR ENVIRONMENTAL & FECAL SAMPLES,
BY COUNTRY, 2024–2031 (USD MILLION) 247
TABLE 152 POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 249
TABLE 153 POULTRY DIAGNOSTICS MARKET FOR VETERINARY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 250
TABLE 154 POULTRY DIAGNOSTICS MARKET FOR INTEGRATED POULTRY PRODUCERS,
BY COUNTRY, 2024–2031 (USD MILLION) 252
TABLE 155 POULTRY DIAGNOSTICS MARKET FOR GOVERNMENT & REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 253
TABLE 156 POULTRY DIAGNOSTICS MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 255
TABLE 157 POULTRY DIAGNOSTICS MARKET FOR OTHER SPECIALIZED LABORATORIES,
BY COUNTRY, 2024–2031 (USD MILLION) 257
TABLE 158 POULTRY DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 260
TABLE 159 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 262
TABLE 160 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 262
TABLE 161 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 263
TABLE 162 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 263
TABLE 163 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 264
TABLE 164 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 264
TABLE 165 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 265
TABLE 166 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 265
TABLE 167 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 265
TABLE 168 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 169 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 266
TABLE 170 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 171 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 172 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 268
TABLE 173 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 268
TABLE 174 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 269
TABLE 175 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 269
TABLE 176 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 270
TABLE 177 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 270
TABLE 178 US: KEY MACROINDICATORS 271
TABLE 179 US: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 272
TABLE 180 US: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 181 US: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 182 US: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 273
TABLE 183 US: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 184 US: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 185 US: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 274
TABLE 186 US: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 275
TABLE 187 US: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 275
TABLE 188 US: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 276
TABLE 189 US: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 276
TABLE 190 US: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 277
TABLE 191 CANADA: KEY MACROINDICATORS 278
TABLE 192 CANADA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 278
TABLE 193 CANADA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 194 CANADA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 195 CANADA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 279
TABLE 196 CANADA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 197 CANADA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 198 CANADA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 281
TABLE 199 CANADA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 281
TABLE 200 CANADA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 282
TABLE 201 CANADA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 282
TABLE 202 CANADA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 283
TABLE 203 CANADA: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 283
TABLE 204 EUROPE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 285
TABLE 205 EUROPE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 285
TABLE 206 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 286
TABLE 207 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 286
TABLE 208 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 287
TABLE 209 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 287
TABLE 210 EUROPE: POULTRY DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 288
TABLE 211 EUROPE: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 288
TABLE 212 EUROPE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 213 EUROPE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 214 EUROPE: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 289
TABLE 215 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 216 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 217 EUROPE: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 291
TABLE 218 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 291
TABLE 219 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 292
TABLE 220 EUROPE: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 292
TABLE 221 EUROPE: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 293
TABLE 222 EUROPE: POULTRY DIAGNOSTICS MARKET, BY END USER, 2
024–2031 (USD MILLION) 293
TABLE 223 GERMANY: KEY MACROINDICATORS 294
TABLE 224 GERMANY: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 294
TABLE 225 GERMANY: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 226 GERMANY: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 227 GERMANY: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 295
TABLE 228 GERMANY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 229 GERMANY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 230 GERMANY: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 297
TABLE 231 GERMANY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 297
TABLE 232 GERMANY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 298
TABLE 233 GERMANY: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 298
TABLE 234 GERMANY: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 299
TABLE 235 GERMANY: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 299
TABLE 236 UK: KEY MACROINDICATORS 300
TABLE 237 UK: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 300
TABLE 238 UK: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 301
TABLE 239 UK: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 301
TABLE 240 UK: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 301
TABLE 241 UK: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 242 UK: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 243 UK: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 303
TABLE 244 UK: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 303
TABLE 245 UK: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 304
TABLE 246 UK: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 304
TABLE 247 UK: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 305
TABLE 248 UK: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 305
TABLE 249 FRANCE: KEY MACROINDICATORS 306
TABLE 250 FRANCE: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 306
TABLE 251 FRANCE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 252 FRANCE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 253 FRANCE: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 307
TABLE 254 FRANCE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 255 FRANCE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 256 FRANCE: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 309
TABLE 257 FRANCE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 309
TABLE 258 FRANCE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 310
TABLE 259 FRANCE: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 310
TABLE 260 FRANCE: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 311
TABLE 261 FRANCE: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 311
TABLE 262 ITALY: KEY MACROINDICATORS 312
TABLE 263 ITALY: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 312
TABLE 264 ITALY: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 265 ITALY: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 266 ITALY: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 313
TABLE 267 ITALY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 268 ITALY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 269 ITALY: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 315
TABLE 270 ITALY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 315
TABLE 271 ITALY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 316
TABLE 272 ITALY: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 316
TABLE 273 ITALY: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 317
TABLE 274 ITALY: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 317
TABLE 275 SPAIN: KEY MACROINDICATORS 318
TABLE 276 SPAIN: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 318
TABLE 277 SPAIN: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 278 SPAIN: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 279 SPAIN: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 319
TABLE 280 SPAIN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 320
TABLE 281 SPAIN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 320
TABLE 282 SPAIN: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 321
TABLE 283 SPAIN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 321
TABLE 284 SPAIN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 322
TABLE 285 SPAIN: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 322
TABLE 286 SPAIN: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 323
TABLE 287 SPAIN: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 323
TABLE 288 NETHERLANDS: KEY MACROINDICATORS 324
TABLE 289 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 324
TABLE 290 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 291 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 292 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 326
TABLE 293 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 326
TABLE 294 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 327
TABLE 295 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 327
TABLE 296 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 328
TABLE 297 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 328
TABLE 298 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 329
TABLE 299 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 329
TABLE 300 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 330
TABLE 301 POLAND: KEY MACROINDICATORS 331
TABLE 302 POLAND: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 331
TABLE 303 POLAND: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 304 POLAND: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 305 POLAND: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 332
TABLE 306 POLAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 307 POLAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 333
TABLE 308 POLAND: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 333
TABLE 309 POLAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 334
TABLE 310 POLAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 334
TABLE 311 POLAND: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 335
TABLE 312 POLAND: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 335
TABLE 313 POLAND: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 336
TABLE 314 RUSSIA: KEY MACROINDICATORS 337
TABLE 315 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 337
TABLE 316 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 337
TABLE 317 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 338
TABLE 318 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 338
TABLE 319 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 338
TABLE 320 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 321 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 339
TABLE 322 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 340
TABLE 323 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 340
TABLE 324 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 341
TABLE 325 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 341
TABLE 326 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 342
TABLE 327 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 342
TABLE 328 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 343
TABLE 329 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 343
TABLE 330 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 343
TABLE 331 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 344
TABLE 332 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 344
TABLE 333 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 345
TABLE 334 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 345
TABLE 335 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 346
TABLE 336 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 346
TABLE 337 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 347
TABLE 338 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 347
TABLE 339 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 350
TABLE 340 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 350
TABLE 341 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (THOUSAND TESTS) 351
TABLE 342 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (THOUSAND ANIMALS) 351
TABLE 343 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 352
TABLE 344 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 352
TABLE 345 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 353
TABLE 346 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 353
TABLE 347 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 354
TABLE 348 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 354
TABLE 349 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 354
TABLE 350 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 355
TABLE 351 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 355
TABLE 352 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 356
TABLE 353 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 356
TABLE 354 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 357
TABLE 355 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 357
TABLE 356 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 358
TABLE 357 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 358
TABLE 358 CHINA: KEY MACROINDICATORS 359
TABLE 359 CHINA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 360
TABLE 360 CHINA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 360
TABLE 361 CHINA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 360
TABLE 362 CHINA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 361
TABLE 363 CHINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 361
TABLE 364 CHINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 362
TABLE 365 CHINA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 362
TABLE 366 CHINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 363
TABLE 367 CHINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 363
TABLE 368 CHINA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 364
TABLE 369 CHINA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 364
TABLE 370 CHINA: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 365
TABLE 371 JAPAN: KEY MACROINDICATORS 366
TABLE 372 JAPAN: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 366
TABLE 373 JAPAN: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 367
TABLE 374 JAPAN: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 367
TABLE 375 JAPAN: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 367
TABLE 376 JAPAN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 368
TABLE 377 JAPAN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 368
TABLE 378 JAPAN: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 369
TABLE 379 JAPAN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 369
TABLE 380 JAPAN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 370
TABLE 381 JAPAN: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 370
TABLE 382 JAPAN: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 371
TABLE 383 JAPAN: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 371
TABLE 384 INDIA: KEY MACROINDICATORS 372
TABLE 385 INDIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 372
TABLE 386 INDIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 373
TABLE 387 INDIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 373
TABLE 388 INDIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 373
TABLE 389 INDIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 374
TABLE 390 INDIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 374
TABLE 391 INDIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 375
TABLE 392 INDIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 375
TABLE 393 INDIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 376
TABLE 394 INDIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 376
TABLE 395 INDIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 377
TABLE 396 INDIA: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 377
TABLE 397 AUSTRALIA: KEY MACROINDICATORS 378
TABLE 398 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 378
TABLE 399 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 379
TABLE 400 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 379
TABLE 401 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 379
TABLE 402 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 380
TABLE 403 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 380
TABLE 404 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 381
TABLE 405 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 381
TABLE 406 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 382
TABLE 407 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 382
TABLE 408 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 383
TABLE 409 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 383
TABLE 410 SOUTH KOREA: KEY MACROINDICATORS 384
TABLE 411 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 384
TABLE 412 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 385
TABLE 413 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 385
TABLE 414 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 385
TABLE 415 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 386
TABLE 416 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 386
TABLE 417 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 387
TABLE 418 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 387
TABLE 419 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 388
TABLE 420 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 388
TABLE 421 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 389
TABLE 422 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 389
TABLE 423 THAILAND: KEY MACROINDICATORS 390
TABLE 424 THAILAND: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 390
TABLE 425 THAILAND: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 391
TABLE 426 THAILAND: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 391
TABLE 427 THAILAND: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 391
TABLE 428 THAILAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 392
TABLE 429 THAILAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 392
TABLE 430 THAILAND: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 393
TABLE 431 THAILAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 393
TABLE 432 THAILAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 394
TABLE 433 THAILAND: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 394
TABLE 434 THAILAND: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 395
TABLE 435 THAILAND: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 395
TABLE 436 NEW ZEALAND: KEY MACROINDICATORS 396
TABLE 437 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 396
TABLE 438 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 397
TABLE 439 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 397
TABLE 440 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 397
TABLE 441 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 398
TABLE 442 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 398
TABLE 443 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 399
TABLE 444 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 399
TABLE 445 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 400
TABLE 446 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 400
TABLE 447 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 401
TABLE 448 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 401
TABLE 449 INDONESIA: KEY MACROINDICATORS 402
TABLE 450 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 402
TABLE 451 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES
& REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 403
TABLE 452 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 403
TABLE 453 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 403
TABLE 454 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 404
TABLE 455 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 404
TABLE 456 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 405
TABLE 457 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 405
TABLE 458 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 406
TABLE 459 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 406
TABLE 460 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 407
TABLE 461 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 407
TABLE 462 PHILIPPINES: KEY MACROINDICATORS 408
TABLE 463 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 408
TABLE 464 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 409
TABLE 465 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 409
TABLE 466 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 409
TABLE 467 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 410
TABLE 468 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 410
TABLE 469 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 411
TABLE 470 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 411
TABLE 471 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 412
TABLE 472 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 412
TABLE 473 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 413
TABLE 474 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 413
TABLE 475 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 414
TABLE 476 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 414
TABLE 477 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 415
TABLE 478 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 415
TABLE 479 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 416
TABLE 480 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 416
TABLE 481 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 417
TABLE 482 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 417
TABLE 483 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 418
TABLE 484 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 418
TABLE 485 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 419
TABLE 486 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 419
TABLE 487 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 421
TABLE 488 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 421
TABLE 489 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 422
TABLE 490 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 422
TABLE 491 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 423
TABLE 492 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 423
TABLE 493 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 424
TABLE 494 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 424
TABLE 495 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 424
TABLE 496 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 425
TABLE 497 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 425
TABLE 498 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 426
TABLE 499 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 426
TABLE 500 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 427
TABLE 501 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 427
TABLE 502 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 428
TABLE 503 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 428
TABLE 504 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 429
TABLE 505 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 429
TABLE 506 BRAZIL: KEY MACROINDICATORS 430
TABLE 507 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 430
TABLE 508 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 431
TABLE 509 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 431
TABLE 510 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 431
TABLE 511 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 432
TABLE 512 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 432
TABLE 513 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 433
TABLE 514 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 433
TABLE 515 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 434
TABLE 516 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 434
TABLE 517 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 435
TABLE 518 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 435
TABLE 519 MEXICO: KEY MACROINDICATORS 436
TABLE 520 MEXICO: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 436
TABLE 521 MEXICO: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS,
BY TYPE, 2024–2031 (USD MILLION) 437
TABLE 522 MEXICO: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 437
TABLE 523 MEXICO: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 437
TABLE 524 MEXICO: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 438
TABLE 525 MEXICO: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 438
TABLE 526 MEXICO: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 439
TABLE 527 MEXICO: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 439
TABLE 528 MEXICO: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 440
TABLE 529 MEXICO: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 440
TABLE 530 MEXICO: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 441
TABLE 531 MEXICO: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 441
TABLE 532 ARGENTINA: KEY MACROINDICATORS 442
TABLE 533 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 442
TABLE 534 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 443
TABLE 535 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 443
TABLE 536 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE,
2024–2031 (USD MILLION) 443
TABLE 537 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 444
TABLE 538 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY TYPE, 2024–2031 (USD MILLION) 444
TABLE 539 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE,
2024–2031 (USD MILLION) 445
TABLE 540 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 445
TABLE 541 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 446
TABLE 542 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS,
BY POULTRY TYPE, 2024–2031 (USD MILLION) 446
TABLE 543 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE,
2024–2031 (USD MILLION) 447
TABLE 544 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 447
TABLE 545 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 448
TABLE 546 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 448
TABLE 547 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 449
TABLE 548 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 449
TABLE 549 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 450
TABLE 550 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 450
TABLE 551 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 451
TABLE 552 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 451
TABLE 553 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 452
TABLE 554 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 452
TABLE 555 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 453
TABLE 556 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 453
TABLE 557 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 455
TABLE 558 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (THOUSAND UNITS) 455
TABLE 559 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 456
TABLE 560 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 456
TABLE 561 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 457
TABLE 562 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 457
TABLE 563 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY REGION, 2024–2031 (USD MILLION) 458
TABLE 564 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 458
TABLE 565 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 458
TABLE 566 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 459
TABLE 567 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 459
TABLE 568 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 460
TABLE 569 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 460
TABLE 570 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 461
TABLE 571 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 461
TABLE 572 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 462
TABLE 573 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 462
TABLE 574 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 463
TABLE 575 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 463
TABLE 576 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 464
TABLE 577 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 464
TABLE 578 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 465
TABLE 579 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 465
TABLE 580 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 465
TABLE 581 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 466
TABLE 582 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 466
TABLE 583 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 467
TABLE 584 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 467
TABLE 585 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 468
TABLE 586 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 468
TABLE 587 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 469
TABLE 588 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 469
TABLE 589 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 470
TABLE 590 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 470
TABLE 591 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 471
TABLE 592 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 471
TABLE 593 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 471
TABLE 594 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 472
TABLE 595 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 472
TABLE 596 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 473
TABLE 597 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 473
TABLE 598 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 474
TABLE 599 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 474
TABLE 600 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 475
TABLE 601 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 475
TABLE 602 UNITED ARAB EMIRATES: KEY MACROINDICATORS 476
TABLE 603 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 476
TABLE 604 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 477
TABLE 605 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS,
BY TYPE, 2024–2031 (USD MILLION) 477
TABLE 606 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 477
TABLE 607 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 478
TABLE 608 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 478
TABLE 609 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 479
TABLE 610 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 479
TABLE 611 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 480
TABLE 612 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 480
TABLE 613 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 481
TABLE 614 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 481
TABLE 615 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 482
TABLE 616 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 482
TABLE 617 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 483
TABLE 618 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 483
TABLE 619 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 620 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 621 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 485
TABLE 622 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 485
TABLE 623 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 486
TABLE 624 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 486
TABLE 625 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 487
TABLE 626 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 487
TABLE 627 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 488
TABLE 628 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 488
TABLE 629 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 489
TABLE 630 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY TEST TYPE, 2024–2031 (USD MILLION) 489
TABLE 631 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET
FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 490
TABLE 632 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET
FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 490
TABLE 633 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY DISEASE TYPE, 2024–2031 (USD MILLION) 491
TABLE 634 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 491
TABLE 635 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR
ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 492
TABLE 636 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 492
TABLE 637 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY SAMPLE TYPE, 2024–2031 (USD MILLION) 493
TABLE 638 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 493
TABLE 639 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN POULTRY
DIAGNOSTICS MARKET 494
TABLE 640 POULTRY DIAGNOSTICS MARKET: DEGREE OF COMPETITION 498
TABLE 641 US POULTRY DIAGNOSTICS MARKET: DEGREE OF COMPETITION 499
TABLE 642 EUROPE POULTRY DIAGNOSTICS MARKET: DEGREE OF COMPETITION 500
TABLE 643 POULTRY DIAGNOSTICS MARKET: REGION FOOTPRINT 505
TABLE 644 POULTRY DIAGNOSTICS MARKET: PRODUCT TYPE FOOTPRINT 506
TABLE 645 POULTRY DIAGNOSTICS MARKET: TEST TYPE FOOTPRINT 507
TABLE 646 POULTRY DIAGNOSTICS MARKET: DISEASE TYPE FOOTPRINT 508
TABLE 647 POULTRY DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 511
TABLE 648 POULTRY DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS 512
TABLE 649 POULTRY DIAGNOSTICS MARKET: PRODUCT LAUNCHES,
JANUARY 2022–FEBRUARY 2026 515
TABLE 650 POULTRY DIAGNOSTICS MARKET: DEALS, JANUARY 2022–FEBRUARY 2026 515
TABLE 651 POULTRY DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022–FEBRUARY 2026 516
TABLE 652 POULTRY DIAGNOSTICS MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–FEBRUARY 2026 517
TABLE 653 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 518
TABLE 654 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED 519
TABLE 655 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 522
TABLE 656 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 524
TABLE 657 ZOETIS SERVICES LLC: COMPANY OVERVIEW 526
TABLE 658 ZOETIS SERVICES LLC: PRODUCTS OFFERED 528
TABLE 659 ZOETIS SERVICES LLC: DEALS, JANUARY 2022−FEBRUARY 2026 528
TABLE 660 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022−FEBRUARY 2026 529
TABLE 661 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS, JANUARY 2022−FEBRUARY 2026 529
TABLE 662 BIOCHEK: COMPANY OVERVIEW 531
TABLE 663 BIOCHEK: PRODUCTS OFFERED 531
TABLE 664 BIOCHEK: PRODUCT LAUNCHES, JANUARY 2022−FEBRUARY 2026 533
TABLE 665 BIOCHEK: DEALS, JANUARY 2022–FEBRUARY 2026 534
TABLE 666 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW 536
TABLE 667 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED 536
TABLE 668 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS,
JANUARY 2022−FEBRUARY 2026 539
TABLE 669 BIONOTE: COMPANY OVERVIEW 541
TABLE 670 BIONOTE: PRODUCTS OFFERED 541
TABLE 671 BIONOTE: DEALS, JANUARY 2022−FEBRUARY 2026 542
TABLE 672 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 543
TABLE 673 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 544
TABLE 674 GD: COMPANY OVERVIEW 545
TABLE 675 GD: PRODUCTS OFFERED 545
TABLE 676 GD: PRODUCT LAUNCHES, JANUARY 2022−FEBRUARY 2026 548
TABLE 677 GD: DEALS, JANUARY 2022−FEBRUARY 2026 548
TABLE 678 GD: EXPANSIONS, JANUARY 2022−FEBRUARY 2026 548
TABLE 679 GD: OTHER DEVELOPMENTS, JANUARY 2022−FEBRUARY 2026 549
TABLE 680 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW 550
TABLE 681 INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED 551
TABLE 682 INDICAL BIOSCIENCE GMBH: PRODUCT ENHANCEMENTS, JANUARY 2022−FEBRUARY 2026 552
TABLE 683 SHENZHEN BIOEASY BIOTECHNOLOGY, INC: COMPANY OVERVIEW 553
TABLE 684 SHENZHEN BIOEASY BIOTECHNOLOGY, INC: PRODUCTS OFFERED 553
TABLE 685 RING BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 554
TABLE 686 RING BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 555
TABLE 687 RING BIOTECHNOLOGY CO., LTD.: PRODUCT LAUNCHES,
JANUARY 2022−FEBRUARY 2026 556
TABLE 688 BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW 557
TABLE 689 BIO-X DIAGNOSTICS S.A.: PRODUCTS OFFERED 557
TABLE 690 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW 559
TABLE 691 MEGACOR DIAGNOSTIK GMBH: PRODUCTS OFFERED 560
TABLE 692 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW 562
TABLE 693 GOLD STANDARD DIAGNOSTICS: PRODUCTS OFFERED 562
TABLE 694 GOLD STANDARD DIAGNOSTICS: OTHER DEVELOPMENTS,
JANUARY 2022−FEBRUARY 2026 564
TABLE 695 BIONEER CORPORATION: COMPANY OVERVIEW 565
TABLE 696 BIONEER CORPORATION: PRODUCTS OFFERED 566
TABLE 697 ELABSCIENCE, INC.: COMPANY OVERVIEW 567
TABLE 698 BIOSELLAL: COMPANY OVERVIEW 568
TABLE 699 BIOGAL: COMPANY OVERVIEW 569
TABLE 700 BIOSTONE ANIMAL HEALTH: COMPANY OVERVIEW 570
TABLE 701 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.: COMPANY OVERVIEW 574
TABLE 702 ABBEXA: COMPANY OVERVIEW 575
TABLE 703 BIOINGENTECH: COMPANY OVERVIEW 576
TABLE 704 AFFIGEN INC.: COMPANY OVERVIEW 579
TABLE 705 ALVEO TECHNOLOGIES: COMPANY OVERVIEW 580
TABLE 706 HIMEDIA LABORATORIES: COMPANY OVERVIEW 581
TABLE 707 RISK ASSESSMENT ANALYSIS 598

LIST OF FIGURES

FIGURE 1 POULTRY DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE 50
FIGURE 2 MARKET SCENARIO 55
FIGURE 3 GLOBAL POULTRY DIAGNOSTICS MARKET, 2024–2031 56
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET, 2020–2025 56
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF POULTRY DIAGNOSTICS MARKET 57
FIGURE 6 HIGH-GROWTH SEGMENTS IN POULTRY DIAGNOSTICS MARKET, 2026–2031 58
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN POULTRY DIAGNOSTICS MARKET,
IN TERMS OF VALUE, DURING FORECAST PERIOD 59
FIGURE 8 INCREASING POULTRY DISEASE SURVEILLANCE TO FUEL MARKET GROWTH 60
FIGURE 9 CONSUMABLES & REAGENTS SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 61
FIGURE 10 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 62
FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 63
FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 64
FIGURE 13 POULTRY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 65
FIGURE 14 POULTRY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 75
FIGURE 15 POULTRY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS 80
FIGURE 16 POULTRY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 82
FIGURE 17 POULTRY DIAGNOSTICS MARKET: ECOSYSTEM ANALYSIS 83
FIGURE 18 AVERAGE SELLING PRICE OF POULTRY DIAGNOSTIC PRODUCTS,
BY KEY PLAYER, 2025 84
FIGURE 19 AVERAGE SELLING PRICE OF ELISA KITS AND REAGENTS AND PCR REAGENTS
AND KITS, BY REGION, 2025 85
FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 91
FIGURE 21 POULTRY DIAGNOSTICS MARKET: INVESTMENT & FUNDING SCENARIO 92
FIGURE 22 POULTRY DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2015–FEBRUARY 2026) 105
FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR POULTRY DIAGNOSTIC
PATENTS (JANUARY 2015–FEBRUARY 2026) 106
FIGURE 24 AI USE CASES 109
FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR POULTRY
DIAGNOSTIC PRODUCTS 116
FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS 117
FIGURE 27 POULTRY DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT 259
FIGURE 28 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET SNAPSHOT 261
FIGURE 29 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET SNAPSHOT 349
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS
MARKET (2021−2025) 496
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS
MARKET (2025) 497
FIGURE 32 US MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2025) 498
FIGURE 33 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2025) 499
FIGURE 34 RANKING OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET, 2025 500
FIGURE 35 POULTRY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 503
FIGURE 36 POULTRY DIAGNOSTICS MARKET: COMPANY FOOTPRINT 504
FIGURE 37 POULTRY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 510
FIGURE 38 POULTRY DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 513
FIGURE 39 R&D EXPENDITURE OF KEY PLAYERS IN POULTRY DIAGNOSTICS
MARKET, 2022−2025 513
FIGURE 40 EV/EBITDA OF KEY VENDORS 514
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 514
FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 519
FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 523
FIGURE 44 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2025) 527
FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 544
FIGURE 46 BIONEER CORPORATION: COMPANY SNAPSHOT (2025) 566
FIGURE 47 POULTRY DIAGNOSTICS MARKET: RESEARCH DESIGN 582
FIGURE 48 PRIMARY SOURCES 584
FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION (SUPPLY SIDE) 586
FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION,
AND REGION (DEMAND SIDE) 587
FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 587
FIGURE 52 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 588
FIGURE 53 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 588
FIGURE 54 REVENUE ANALYSIS OF TOP FIVE COMPANIES: POULTRY DIAGNOSTICS
MARKET (2025) 589
FIGURE 55 DEMAND-SIDE MARKET ESTIMATION FOR POULTRY DIAGNOSTIC
CONSUMABLES & REAGENTS 590
FIGURE 56 DEMAND-SIDE MARKET ESTIMATION FOR POULTRY DIAGNOSTIC INSTRUMENTS 592
FIGURE 57 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF POULTRY DIAGNOSTICS MARKET (2026–2031) 593
FIGURE 58 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 593
FIGURE 59 TOP-DOWN APPROACH 594
FIGURE 60 BOTTOM-UP APPROACH 595
FIGURE 61 MARKET DATA TRIANGULATION METHODOLOGY 596

---

---